Skip to content

Clinical trials

Terminated Phase 2 Carcinoma, Transitional Cell trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Transitional Cell Phase: Phase 2 Status: Terminated Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20051
20091
20102
20111
20131
20152
20161
20174
20184
20192
20205
20212
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated30

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Incyte Corporation2
M.D. Anderson Cancer Center2
Arjun Balar, MD1
BIND Therapeutics1
Case Comprehensive Cancer Center1
Centre Hospitalier Universitaire de Saint Etienne1
Cliniques universitaires Saint-Luc- Université Catholique de Louvain1
Dendreon1
European Association of Urology Research Foundation1
G1 Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Transitional Cell30
Urinary Bladder Neoplasms10
Carcinoma, Renal Cell2
Ureteral Neoplasms2
Urethral Neoplasms2
Acrocephalosyndactylia1
Brain Neoplasms1
Carcinoma, Non-Small-Cell Lung1
Cholangiocarcinoma1
Melanoma1

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.